Chinese smartphone manufacturer Xiaomi Corp. recently marked its foray into the drone market by unveiling its first drone -- called 'Mi Drone' -- at a glitzy press event held in mainland China on Wednesday.
The Xiaomi Mi Drone is a low-cost blocky quadcopter, equipped with a built-in camera that has the capability to shoot up to 4K video.
The camera of the Mi Drone will be a 12.4-megapixel, 360-degree, RAW-capable camera, featuring a 3-axis self-stabilizing gimble which will be capable of making up to 2,000 tilt corrections per second.
The remote of the Xiaomi Mi Drone will come with a dial for making adjustments to camera tilt; a dedicated shutter button; a button for the drone's take-off and landing; a built-in slot for smartphone; and antennas with up to 2km radio control range. In addition, the drone will have a 5,100mAh battery, which will give it a flying time of up to 27 minutes; and a range of 3km.
The Mi Drone is scheduled for shipping later this year, in two models --- a low-end, 1080p model; and a high-end model with 4K 30fps configuration. The cost of the 1080p model will be $380, while the 4K configuration will be priced at $450.
In a Friday announcement, Microsoft-owned game developer Mojang said that it has partnered with Chinese software publisher NetEase to launch a version of the popular Minecraft game in China.
The Mojang-NetEase deal -- the financial terms...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
China's Dakang Australia has been looking forward to sign a deal to buy Kidman, one of the Australia's biggest beef producers and owner of farm assets. However, the deal could be cancelled as the Australian government said it found that selling...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In a Thursday post on the company blog, Alphabet Inc. subsidiary Google announced the launch of...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
During the course of Thursday proceedings in the ongoing...
In an announcement made at the I/O developer conference...
In a recent blog post, distinguished Google hardware...
According to a Venturebeat report, Chinese device...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).